Antibody profiling with protein antigen microarrays in early stage cancer

Bibliography

• Finn OJ. Immune response as a biomarker for cancer detection and a lot more. N Engl J Med 2005;353:1288-90
   PubMed Web of Science ®Google Scholar
• Liang T, Hiipakka RA, Stebbins J, Liao S. Anti-5-alpha-reductase autoantibodies in the serum of patients with prostatic cancer. J Clin Endocrinol Metab 1990;71:1666-8
   PubMed Web of Science ®Google Scholar
• Lang C, Unteregger G, Kartarius S, p53 autoantibodies in patients with urological tumours. Br J Urol 1998;82:721-6
   PubMedGoogle Scholar
• Nilsson BO, Carlsson L, Larsson A, Ronquist G. Autoantibodies to prostasomes as new markers for prostate cancer. Ups J Med Sci 2001;106:43-39
   PubMed Web of Science ®Google Scholar
• Mintz PJ, Kim J, Do K-A, Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 2003;21:57-63
   PubMed Web of Science ®Google Scholar
• Mollick JA, Hoki FS, Soiffer RJ, MUC-1 like tandem repeat proteins are broadly immunogenic in cancer patients. Cancer Immunol 2003;3:3
   PubMedGoogle Scholar
• Taylor DD, Gercel-Taylor C, Parker LP. Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol Oncol 2009;115:112-20
   PubMed Web of Science ®Google Scholar
• Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 2001;108:1411-15
   PubMed Web of Science ®Google Scholar
• Zhang J-Y, Casiano CA, Peng X-X, Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev 2003;12:136-43
   PubMed Web of Science ®Google Scholar
• Zhang J-Y. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. Cancer Detect Prev 2004;28:114-18
   PubMedGoogle Scholar
• Sahin U, Tureci O, Schmitt H, Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995;92:11810-13
   PubMed Web of Science ®Google Scholar
• Tureci O, Sahin U, Pfreundschuh M. Serological analysis of human tumor antigens: molecular definition and implications. Mol Med Today 1997;3:342-9
   PubMedGoogle Scholar
• Li G, Miles A, Line A, Rees RC. Identification of tumour antigens by serological analysis of cDNA expression cloning. Cancer Immunol Immunother 2004;53:139-43
   PubMed Web of Science ®Google Scholar
• Available from: http://ludwig-sun5.unil.ch/CancerImmunomeDB
   Google Scholar
• Shimizu K, Katoh H, Yamashita F, Comparison of carbohydrate structures of serum alpha-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis. Clin Chim Acta 1996;254:23-40
   PubMed Web of Science ®Google Scholar
• Thompson S, Cantwell BM, Cornell C, Turner GA. Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis. Br J Cancer 1991;64:386-90
   PubMed Web of Science ®Google Scholar
• Van Dijk W, Havenaar EC, Brinkman-van der Linden EC. Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconj J 1995;12:227-33
   PubMed Web of Science ®Google Scholar
• Thompson S, Guthrie D, Turner GA. Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer. Br J Cancer 1988;58:589-93
   PubMed Web of Science ®Google Scholar
• Reis CA, David L, Seixas M, Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer 1998;79:402-10
   PubMed Web of Science ®Google Scholar
• Lloyd KO, Burchell J, Kudryashov V, Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem 1996;271:33325-34
   PubMed Web of Science ®Google Scholar
• Gunawardana CG, Diamandis EP. High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Lett 2007;249:110-19
   PubMed Web of Science ®Google Scholar
• Wang X, Yu J, Sreekumar A, Autoantibody signatures in prostate cancer. N Engl J Med 2005;353:1224-35
   PubMed Web of Science ®Google Scholar
• Zhong L, Coe SP, Stromberg AJ, Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006;1:513-19
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Mohapatra S, Ionan A, Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006;66:1181-90
   PubMed Web of Science ®Google Scholar
• Zhong L, Ge K, Zu JC, Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res 2008;10:R40
   PubMed Web of Science ®Google Scholar
• Available from: www.invitrogen.com
   Google Scholar
• Hudson ME, Pozdnyakova I, Haines K, Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA 2007;104:17494-9
   PubMed Web of Science ®Google Scholar
• Gunawardana CG, Memari N, Diamandis EP. Identifying novel autoantibody signatures in ovarian cancer using high-density protein microarrays. Clin Biochem 2009;42:426-9
   PubMed Web of Science ®Google Scholar
• Gnjatic S, Ritter E, Suchler MW, Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci USA 2010;107:5088-93
   PubMed Web of Science ®Google Scholar
• Babel I, Barderas R, Diaz-Uriarte R, Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays. Mol Cell Proteomics 2009;8:2382-95
   PubMed Web of Science ®Google Scholar
• Ehrlich JR, Caiazzo RJ Jr, Qiu W, A native antigen “reverse capture” microarray platform for autoantibody profiling of prostate cancer sera. Proteomics Clin Appl 2007;1:476-85
   PubMed Web of Science ®Google Scholar
• Ehrlich JR, Qin S, Liu BCS. The “reverse capture” autoantibody microarray: a native antigen-based platform for autoantibody profiling. Nat Protoc 2006;1:452-60
   PubMed Web of Science ®Google Scholar
• O'Rourke DJ, DiJohnson DA, Caiazzo RJ, Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with elevated serum prostate specific antigen. Clin Chim Acta 2012;413:561-7
   PubMed Web of Science ®Google Scholar
• Tang L, Yang J, Ng S-K, Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer. Eur J Cancer 2010;46:170-9
   PubMed Web of Science ®Google Scholar
• Cramer DW, O'Rourke DJ, Vitonis AF, CA125 immune complexes in ovarian cancer patients with low CA125 concentrations. Clin Chem 2010;56:1889-92
   PubMed Web of Science ®Google Scholar
• Qiu J, Madoz-Gurpide J, Misek DE, Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res 2004;3:261-7
   PubMed Web of Science ®Google Scholar
• Bouwman K, Qiu J, Zhou H, Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity. Proteomics 2003;3:2200-7
   PubMed Web of Science ®Google Scholar
• Caiazzo RJ Jr, O'Rourke DJ, Barker TJ, Native antigen fractionation protein microarrays for biomarker discovery. Methods Mol Biol 2011;723:129-48
   PubMedGoogle Scholar
• Groathouse NA, Amin A, Marques MAM, Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles. Infect Immun 2006;74:6458-66
   PubMed Web of Science ®Google Scholar
• Wandall HH, Blixt O, Tarp MA, Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res 2010;70:1306-13
   PubMed Web of Science ®Google Scholar
• Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin Chem 2006;52:1651-9
   PubMed Web of Science ®Google Scholar
• Angenendt P, Glokler J, Murphy D, Toward optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem 2002;309:253-60
   PubMed Web of Science ®Google Scholar
• Angenendt P, Glokler J, Sobek J, Next generation of protein microarray support materials: evaluation for protein and antibody microarray applications. J Chromatogr A 2003;1009:97-104
   PubMed Web of Science ®Google Scholar
• Kijanka G, Murphy D. Protein arrays as tools for serum autoantibody marker discovery in cancer. J Proteomics 2009;72:936-44
   PubMed Web of Science ®Google Scholar
• Kricka LJ, Master SR. Validation and quality control of protein microarray-based analytical methods. Mol Biotechnol 2008;38:19-31
   PubMed Web of Science ®Google Scholar
• Copeland S, Siddiqui J, Remick D. Direct comparison of traditional ELISAs and membrane protein arrays for detection and quantification of human cytokines. J Immunol Methods 2004;284:99-106
   PubMed Web of Science ®Google Scholar